GB202109375D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB202109375D0
GB202109375D0 GBGB2109375.2A GB202109375A GB202109375D0 GB 202109375 D0 GB202109375 D0 GB 202109375D0 GB 202109375 A GB202109375 A GB 202109375A GB 202109375 D0 GB202109375 D0 GB 202109375D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2109375.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB2109375.2A priority Critical patent/GB202109375D0/en
Publication of GB202109375D0 publication Critical patent/GB202109375D0/en
Priority to IL309257A priority patent/IL309257A/en
Priority to PCT/EP2022/067603 priority patent/WO2023274974A1/en
Priority to KR1020247003055A priority patent/KR20240028449A/en
Priority to AU2022302769A priority patent/AU2022302769A1/en
Ceased legal-status Critical Current

Links

GBGB2109375.2A 2021-06-29 2021-06-29 Combination therapy Ceased GB202109375D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB2109375.2A GB202109375D0 (en) 2021-06-29 2021-06-29 Combination therapy
IL309257A IL309257A (en) 2021-06-29 2022-06-27 Combination therapy using antibody-drug conjugates
PCT/EP2022/067603 WO2023274974A1 (en) 2021-06-29 2022-06-27 Combination therapy using antibody-drug conjugates
KR1020247003055A KR20240028449A (en) 2021-06-29 2022-06-27 Combination therapy using antibody-drug conjugates
AU2022302769A AU2022302769A1 (en) 2021-06-29 2022-06-27 Combination therapy using antibody-drug conjugates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2109375.2A GB202109375D0 (en) 2021-06-29 2021-06-29 Combination therapy

Publications (1)

Publication Number Publication Date
GB202109375D0 true GB202109375D0 (en) 2021-08-11

Family

ID=77179403

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2109375.2A Ceased GB202109375D0 (en) 2021-06-29 2021-06-29 Combination therapy

Country Status (1)

Country Link
GB (1) GB202109375D0 (en)

Similar Documents

Publication Publication Date Title
GB202111288D0 (en) Combination therapy
GB202108303D0 (en) Therapy
GB202004189D0 (en) Combination therapy
IL304223A (en) Combination therapy
GB202109377D0 (en) Combination therapy
GB202109375D0 (en) Combination therapy
GB202109373D0 (en) Combination therapy
GB202107824D0 (en) Combination therapy
GB202107706D0 (en) Combination therapy
GB202107709D0 (en) Combination therapy
GB202107713D0 (en) Combination therapy
GB202104037D0 (en) Combination therapy
GB202015916D0 (en) Combination therapy
GB202012161D0 (en) Combination therapy
GB202009178D0 (en) Combination therapy
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202015780D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)